Tower Research Capital LLC (Trc) 2seventy Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,428 shares of TSVT stock, worth $11,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,428
Previous 2,655
66.78%
Holding current value
$11,557
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TSVT
# of Institutions
127Shares Held
44.8MCall Options Held
17.3KPut Options Held
2.9K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$15.5 Million1.11% of portfolio
-
Goldman Sachs Group Inc New York, NY4.29MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$9.82 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$9.56 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$7.62 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $98.9M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...